The Business Of Golf As PGA Tour Season Arrives
Zacks Investment Research | Jan 08, 2018 02:59AM ET
Welcome to the latest episode of Full-Court Finance, the podcast from Zacks Investment Research focused on the intersection of sports, business, and the stock market. On this week’s episode, Zacks producer and avid golfer Daniel MacPherson joins the show to discuss the current state of golf and the big business surrounding the PGA Tour as the 2018 season swings into full gear.
The golf world is abuzz with the possibility of a 2018 PGA Tour season that could see the long-awaited return to success for Tiger Woods, as his presence alone often substantially boosts television ratings and overall interest in the sport. With millions of dollars invested in television coverage, the likes of NBC (NASDAQ:CMCSA) , Fox (NASDAQ:FOXA) , CBS (NYSE:CBS) and ESPN (NYSE:DIS) are all actively rooting for Woods—who missed a majority of the last few seasons due to injuries—to remain healthy.
Still, no matter if Woods makes a real comeback or not, the PGA Tour is still a big draw for sponsors as the likes of AT&T (NYSE:T) , FedEx (NYSE:FDX) , Microsoft (NYSE:T) , Dell Technologies (NYSE:DVMT) and many other major companies are all heavily involved in golf through sponsorships and more.
On top of that, despite Nike (NYSE:NKE) exiting the golf equipment business and Adidas (OTC:ADDYY) selling TaylorMade, the two sportswear powers are still major players in golf apparel even as struggling Under Armour (NYSE:UAA) grows its golf segment. What’s more, other golf-focused companies including Titleist and Footjoy owner Acushnet Holdings (NYSE:GOLF) and Callaway Golf (NYSE:ELY) have done well.
Lastly, despite gloomy attitudes about golf’s future, the game and business of golf are far from doomed, as amateur interest continues to be spurred by the rise of fun and recreational golf outlets such as Topgolf.
If you have any questions about this episode of Full-Court Finance please feel free to shoot us an email over at zacks.com/podcast and remember to subscribe and leave a rating in iTunes.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits. Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.